electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

ECOR 11.14.2024

Full Press ReleaseSEC FilingsOur ECOR Tweets

About Gravity Analytica

Recent News

  • 01.07.2025 - electroCore Expands Intellectual Property Portfolio
  • 12.17.2024 - electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
  • 11.20.2024 - electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award

Recent Filings

  • 01.21.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.17.2025 - EX-99.1 EX-99.1
  • 01.17.2025 - 8-K Current report

ROCKAWAY, N.J.,Nov. 14, 2024(GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics andDigital Health & Services Forumtaking place inNew York CityonNovember 21, 2024.

Joshua Lev, Chief Financial Officer, will host one-on-one meetings throughout the day.

To schedule a one-on-one meeting withMr. Lev, investors are encouraged to reach out to their CG representative. For more information regarding the event please visithttps://www.meetmax.com/sched/event_110807/conference_home.html.

About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance inthe United Statesand select overseas markets.

For more information, visitwww.electrocore.com.

Contact

ECOR Investor Relations(973) 302-9253investors@electrocore.com

Primary Logo

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com